Contents

Search

micro-bubble contrast agent

sterile suspension of perflutren gas microspheres Indications: - use in certain patients with suboptimal echocardiograms, to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border Monitor: - high risk patients with pulmonary hypertension or unstable cardiopulmonary conditions - closely monitor during & for at least 30 minutes post administration [1] Adverse effects: - risk of serious cardiopulmonary reactions during or within 30 minutes following the administration [1]

Interactions

drug adverse effects of contrast agents

General

contrast agent

References

  1. FDA MedWatch http://www.fda.gov/medwatch/safety/2008/safety08.htm#Microbubble